发明名称 Oligomeric compounds for the modulation HIF-1αexpression
摘要 Oligonucleotides directed against the hypoxia-inducible factor-1α(HIF-1α) gene are provided for modulating the expression of HIF-1α. The compositions comprise oligonucleotides, particularly antisense oligonucleotides, targeted to nucleic acids encoding the HIF-1α. Methods of using these compounds for modulation of HIF-1αexpression and for the treatment of diseases associated with the hypoxia-inducible factor-1αare provided. Examples of diseases are cancer and pre-eclampsia. The oligonucleotides may be composed of deoxyribonucleosides, a nucleic acid analogue, or Locked Nucleic Acid (LNA) or a combination thereof.
申请公布号 US7737264(B2) 申请公布日期 2010.06.15
申请号 US20030407807 申请日期 2003.04.04
申请人 ENZON PHARMACEUTICALS, INC.;SANTARIS PHARMA A/S 发明人 THRUE CHARLOTTE ALBAEK;HOEG ANJA MOELHART;KRISTJANSEN PAUL E. G.
分类号 C07H21/04;C12N15/09;A61K31/70;A61K31/7088;A61K38/00;A61K45/06;A61K48/00;A61P1/00;A61P3/00;A61P25/28;A61P29/00;A61P35/00;A61P43/00;C07H21/00;C12N15/113 主分类号 C07H21/04
代理机构 代理人
主权项
地址